 |
|
Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s
June 11, 2008New findings by researchers at Columbia University Mailman School of Public Health point to potential to begin colon cancer screening at a younger age
June 9, 2008 -- The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age, according to a study published in the current issue of Gastroenterology, the journal of the American Gastroenterological Association (AGA) Institute. In comparing colonoscopy results by age group, the team of scientists found that in the 40 to 49 age group, 79 patients, or 14 percent, had one or more adenoma or pre-cancerous growth. Similarly, the 50 to 59 age group had 56 patients, or 16 percent, with one or more adenoma.
Data from a centralized digital medical record system were analyzed by a team of researchers led by Alfred I. Neugut, MD, PhD, professor of epidemiology at the Mailman School of Public Health and professor of medicine at Columbia University College of Physicians and Surgeons and head of cancer prevention and control for the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center and New York-Presbyterian Hospital, and Andrew Rundle, PhD, assistant professor of epidemiology at the Mailman School of Public Health. The researchers reviewed 553 screening colonoscopies for patients ages 40 to 49 and 352 screening colonoscopies for patients ages 50 to 59. Individuals who could be deemed "high-risk" because of a family history of colon cancer, a personal history of inflammatory bowel disease, or any malignancy other than skin cancer were excluded from the sample.
Currently, standard protocol recommends screening patients age 50 and over for colon cancer based on the increasing incidence of colon cancer at that age. Because observational studies have shown that it takes a decade for adenomas to develop and progress to cancer, the increase in colon cancer prevalence in the over-50 age group, in fact, may be the result of undetected adenomas that were present in the individuals in their 40s.
"Our results support the theory that adenomas, which later may lead to cancer, form at an age earlier than we screen for today," said Dr. Neugut. "With this information in hand, it is logical to think that if we were to recommend screening for colon cancer at age 40, we may be able to decrease its prevalence even further and save more people from having to battle the disease."
Though the number of adenomas was relatively similar in the two age groups, there was a doubling in the prevalence of abnormal cell growth, or advanced neoplasia, in the 50 to 59 age group versus the 40 to 49 age group. While not statistically significant, in the 40 to 49 age group, 11 patients, or two percent, had an advanced neoplasm, and in the 50 to 59 age group, 13 patients, or four percent, had an advanced neoplasm.
"What this implies is that while the number of pre-cancerous growths is very similar in both age groups, there is a progression toward cancer in older patients," noted Dr. Rundle. "Abnormal cell growth is a warning sign of cancer, so the fact that there's an increase in advanced neoplasia in the older age group is in line with the increased colon cancer incidence we see in individuals over the age of 50. Detecting adenomas when patients are in their 40s could mean that we are able to drastically lower the prevalence of colorectal cancer. Additional studies need to be done to look specifically at this possibility and the cost-benefit of beginning screening at an earlier age."
Only one prior study has investigated the prevalence of colorectal adenomas in average-risk individuals aged 40 to 49 years in the U.S., and it reports very similar findings: an adenoma prevalence of 11 percent in the age group.
Columbia University's Mailman School of Public Health
Currently, standard protocol recommends screening patients age 50 and over for colon cancer based on the increasing incidence of colon cancer at that age. Because observational studies have shown that it takes a decade for adenomas to develop and progress to cancer, the increase in colon cancer prevalence in the over-50 age group, in fact, may be the result of undetected adenomas that were present in the individuals in their 40s.
"Our results support the theory that adenomas, which later may lead to cancer, form at an age earlier than we screen for today," said Dr. Neugut. "With this information in hand, it is logical to think that if we were to recommend screening for colon cancer at age 40, we may be able to decrease its prevalence even further and save more people from having to battle the disease."
Though the number of adenomas was relatively similar in the two age groups, there was a doubling in the prevalence of abnormal cell growth, or advanced neoplasia, in the 50 to 59 age group versus the 40 to 49 age group. While not statistically significant, in the 40 to 49 age group, 11 patients, or two percent, had an advanced neoplasm, and in the 50 to 59 age group, 13 patients, or four percent, had an advanced neoplasm.
"What this implies is that while the number of pre-cancerous growths is very similar in both age groups, there is a progression toward cancer in older patients," noted Dr. Rundle. "Abnormal cell growth is a warning sign of cancer, so the fact that there's an increase in advanced neoplasia in the older age group is in line with the increased colon cancer incidence we see in individuals over the age of 50. Detecting adenomas when patients are in their 40s could mean that we are able to drastically lower the prevalence of colorectal cancer. Additional studies need to be done to look specifically at this possibility and the cost-benefit of beginning screening at an earlier age."
Only one prior study has investigated the prevalence of colorectal adenomas in average-risk individuals aged 40 to 49 years in the U.S., and it reports very similar findings: an adenoma prevalence of 11 percent in the age group.
Columbia University's Mailman School of Public Health
Colon Cancer Current Events and Colon Cancer News RSSBreakthrough optical technology to assess colon cancer risk, accuracy
Researchers at NorthShore University HealthSystem (NorthShore) and Northwestern University have discovered that fiber optic technology can for the very first time effectively measure blood levels in the colonic lining (mucosa) in humans, thus having potential applications for analyzing risk of colon cancer.
Surgical treatment provides new option for some colorectal cancer patients
Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.
Black Americans Are At Greater Risk for Colon Polyps
Black Americans have a higher occurrence of colon polyps, according to a new study. This is a significant finding considering the incidence of colon cancer among black men has increased and remained unchanged among black women during the last 20 years.
Cancer-causing gut bacteria exposed
Normal gut bacteria are thought to be involved in colon cancer but the exact mechanisms have remained unknown. Now, scientists from the USA have discovered that a molecule produced by a common gut bacterium activates signalling pathways that are associated with cancer cells.
Brown-Assisted Trial Finds New Colorectal Screening Procedure Is Accurate and Less Invasive
More patients stand to benefit from a comprehensive, less invasive method to accurately detect colorectal cancer and precancerous polyps, a multicenter study involving Brown University and institutions nationwide has found.
Researchers identify cancer-causing gene in many colon cancers
Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.
'1-hit' event provides new opportunity for colon cancer prevention, say Fox Chase researchers
More than 30 years ago, Alfred Knudson Jr., M.D., Ph.D., revolutionized the field of cancer genetics by showing that a person must lose both their paternal and maternal copies of a particular class of cancer-inhibiting genes, called tumor-suppressor genes, in order to develop cancer.
Early stage colon cancer characterized by inactivation of gatekeeper gene
The absence or inactivation of the RUNX3 gatekeeper gene paves the way for the growth and development of colon cancer, Singapore scientists report in the Sept. issue of the journal Cancer Cell. Previous studies have shown that RUNX3 plays a role in gastric, breast, lung and bladder cancers.
Variation of normal protein could be key to resistance to common cancer drug
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.
Anti-Cancer Flower Power
Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer?
More Colon Cancer Current Events and Colon Cancer News Articles
 | The Colon Cancer Survivors' Guide, Second Edition: Living Stronger, Longer by Curtis Pesmen Based on an award-winning series of Esquire magazine articles on his battle with colon cancer, Pesmen shows how a person stops becomng a patient and starts becoming a survivor. Incluses a chorus of survivors' voices, and casts light on the physical, emotional and psychological needs of those striving to move forward confidently with their lives. New, revised second edition updates treatments and... |
 | American Cancer Society's Complete Guide to Colorectal Caner by American Cancer Society Don't die of embarrassment--get informed about colorectal cancer Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete... |
 | Living With Colon Cancer: Beating the Odds by Eliza Wood Livingston Despite the efforts of Katie Couric to draw attention to the importance of colonoscopy screening for the detection of colon cancer, this cancer still does not receive the publicity devoted to breast, lung, and prostate cancer. Yet colorectal cancer is the third most common malignancy in the world and is the second leading cause of death from cancer next to lung cancer. As a result, colon cancer... |
 | Colon Cancer Answers by Dr. Bruce A. Feinberg One of the greatest failures of public health practices and policy in America is the mismanagement of colon cancer. Despite the fact that colon cancer is 90 percent preventable through safe, accessible, cost-effective screening tests, this terrible disease remains the second leading cause of cancer death. Each year, more than 150,000 Americans will die -- an unnecessary and costly human... |
 | Understanding Colon Cancer by A. Richard, M.D., F.A.C.P. Adrouny For decades, while other cancers grabbed the headlines, colorectal cancer was quietly ignored. The lifetime risk of colorectal cancer in the general population is 2.5 to 5 percent. This means that twenty-five to fifty out of one thousand people will be stricken by this disease. Although data show that in America colorectal cancer incidence and mortality have been waning in recent decades,... |
 | Tell Me What to Eat to Help Prevent Colon Cancer by Elaine Magee Elaine Magee gives you all the information you can never seem to understand when the doctor rattles it off, and she answers all the questions you ever wanted to ask a dietitian about preventing colon cancer. You will find a host of specific recommendations-what to eat, what to avoid, and how to incorporate these changes into your lifestyle. Tell Me What to Eat to Help Prevent Colon Cancer begins... |
 | The Intelligent Patient Guide to Colorectal Cancer: Information, risk, prevention, symptoms, signs, diagnosis, stage, surgery, radiation, chemotherapy, prognosis, treatment of/for colon rectal cancer. by Michael E. Pezim, David A. Owen The Intelligent Patient Guide book series was created in 1989 by a group of American and Canadian-trained physicians frustrated by the lack of quality information available for their cancer patients. The books became bestsellers, and their appeal has grown despite the development of the Internet. Whereas the Internet is an explosion of medical information that can confuse and intimidate, these... |
 | Colon and Rectal Cancer by Peter S. Edelstein Colorectal cancer is the fourth most common type of cancer worldwide yet there continues to be controversy and confusion regarding the best methods and techniques for its diagnosis and management. Colon and Rectal Cancer is a clinician’s guide to major advances, including the tremendous improvements in endorectal ultrasonography, which allow a much more accurate staging of rectal tumors and... |
 | Colon Cancer: Current And Emerging Trends In Detection And Treatment (Cancer and Modern Science) by Mark, M.D. Stokes |
 | Colon Cancer & the Polyps Connection by Stephen Fisher "This book will save many lives, possibly yours or that of a loved one—it arms readers with all the information they need to become informed health-care consumers and protect their own health." Robert Tufft, M.D., Diplomate, American Board of Internal Medicine Colon Cancer & the Polyps Connection is the first-and only book exploring the causes, cures and prevention of colorectal cancer.... |
| © 2008 BrightSurf.com |